Orencia and Infusion related reaction - from FDA reports


Summary

Infusion related reaction is found among people who take Orencia, especially for people who are female, 50-59 old , have been taking the drug for 6 - 12 months, also take medication Rituxan, and have Sjogren syndrome. This review analyzes which people have Infusion related reaction with Orencia. It is created by eHealthMe based on reports of 21,048 people who have side effects when taking Orencia from FDA , and is updated regularly.

What to expect?

If you take Orencia and have Infusion related reaction, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Orencia and have Infusion related reaction

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 18, 2017

21,048 people reported to have side effects when taking Orencia.
Among them, 148 people (0.7%) have Infusion related reaction


Number of reports submitted per year:

Could Orencia cause Infusion related reaction?

Time on Orencia when people have Infusion related reaction *:

  • < 1 month: 29.17 %
  • 1 - 6 months: 16.67 %
  • 6 - 12 months: 41.67 %
  • 1 - 2 years: 8.33 %
  • 2 - 5 years: 4.17 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Infusion related reaction when taking Orencia *:

  • female: 89.6 %
  • male: 10.4 %

Age of people who have Infusion related reaction when taking Orencia *:

  • 0-1: 0.0 %
  • 2-9: 1.1 %
  • 10-19: 0.0 %
  • 20-29: 3.3 %
  • 30-39: 4.4 %
  • 40-49: 19.78 %
  • 50-59: 39.56 %
  • 60+: 31.87 %

Top conditions involved for these people *:

  • Sjogren Syndrome (4 people, 2.70%)
  • High Blood Pressure (3 people, 2.03%)
  • Vasculitis (2 people, 1.35%)
  • Cardiac Disorder (2 people, 1.35%)
  • Psoriatic Arthropathy (1 person, 0.68%)

Top co-used drugs for these people *:

  • Rituxan (40 people, 27.03%)
  • Actemra (29 people, 19.59%)
  • Remicade (25 people, 16.89%)
  • Methotrexate (24 people, 16.22%)
  • Enbrel (23 people, 15.54%)

Top other side effects for these people *:

  • Drug Ineffective (33 people, 22.30%)
  • Rashes (31 people, 20.95%)
  • Pain (16 people, 10.81%)
  • Fatigue (15 people, 10.14%)
  • Hair Loss (14 people, 9.46%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Infusion related reaction when taking Orencia?

Expand the study to include all drugs with the same ingredients

Infusion related reaction and drugs with ingredients of abatacept.

Expand the study to include reports from both FDA and eHealthMe

Infusion related reaction and Orencia from FDA and eHealthMe reports

Orencia

Orencia has active ingredients of abatacept. It is often used in rheumatoid arthritis. (latest outcomes from Orencia 21,288 users)

Infusion related reaction

Infusion related reaction has been reported by people with rheumatoid arthritis, crohn's disease, ulcerative colitis, multiple sclerosis, ankylosing spondylitis (latest reports from 23,829 Infusion related reaction patients).

Browse all side effects of Orencia

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Infusion related reaction

Infusion related reaction

Could your condition cause Infusion related reaction

Infusion related reaction

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Orencia and have Infusion related reaction.

Questions to the study

More questions >

User reviews to the study

More reviews >